DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
H1N1 (Swine Influenza) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in H1N1 (Swine Influenza) Key assessments Patient Segmentation in H1N1 (Swine Influenza) H1N1 (Swine Influenza) Risk & Burden Factors driving growth in a specific H1N1 (Swine Influenza) patient population
January 2022
60 pages
Head and Neck cancer (HNC) - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Head and Neck cancer (HNC) Key assessments Patient Segmentation in Head and Neck cancer (HNC) Head and Neck cancer (HNC) Risk & Burden Factors driving growth in a specific Head and Neck cancer (HNC) patient population ...
January 2022
60 pages
Hemophilia - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Hemophilia Hemophilia Pipeline Analysis Hemophilia Market Size and Trends Hemophilia Market Opportunities Impact of upcoming Therapies in Hemophilia Hemophilia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Hemophilia ...
January 2022
200 pages
Hemophilia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hemophilia Key assessments Patient Segmentation in Hemophilia Hemophilia Risk & Burden Factors driving growth in a specific Hemophilia patient population
January 2022
60 pages
Hereditary Angioedema - Epidemiology Forecast to 2032
US$ 3,950.00
... 48 hours DelveInsight’s “Hereditary Angioedema -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Hereditary Angioedema in seven major markets ... Hereditary Angioedema market. Identifying prevalent patient populations as well as risk factors in the global Hereditary Angioedema ...
January 2022
60 pages
Herpes Simplex - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population The report provides the segmentation of the disease epidemiology by types and diagnosed prevalent cases of HSV infections in 7MM Key strengths 10 Year Forecast of HSV infections epidemiology 7MM ...
January 2022
60 pages
Herpes Zoster - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Herpes Zoster Key assessments Patient Segmentation in Herpes Zoster Herpes Zoster Risk & Burden Factors driving growth in a specific Herpes Zoster patient population
January 2022
60 pages
HIV-associated Lipodystrophy - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in HIV-associated Lipodystrophy Key assessments Patient Segmentation in HIV-associated Lipodystrophy HIV-associated Lipodystrophy Risk & Burden Factors driving growth in a specific HIV-associated Lipodystrophy patient population
January 2022
60 pages
Hodgkin's lymphoma (HL) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hodgkin’s lymphoma (HL) Key assessments Patient Segmentation in Hodgkin’s lymphoma (HL) Hodgkin’s lymphoma (HL) Risk & Burden Factors driving growth in a specific Hodgkin’s lymphoma (HL) patient population
January 2022
60 pages
Human Papillomavirus (HPV) Associated Disorders - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Human Papillomavirus (HPV) Associated Disorders Key assessments Patient Segmentation in Human Papillomavirus (HPV) Associated Disorders Human Papillomavirus (HPV) Associated Disorders Risk & Burden Factors driving growth ...
January 2022
60 pages
Huntington's Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Huntington's Disease Key assessments Patient Segmentation in Huntington's Disease Huntington's Disease Risk & Burden Factors driving growth in a specific Huntington's Disease patient population
January 2022
60 pages
Hypercholesterolemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hypercholesterolemia Key assessments Patient Segmentation in Hypercholesterolemia Hypercholesterolemia Risk & Burden Factors driving growth in a specific Hypercholesterolemia patient population
January 2022
60 pages
Insomnia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Insomnia Key assessments Patient Segmentation in Insomnia Insomnia Risk & Burden Factors driving growth in a specific Insomnia patient population
January 2022
60 pages
Irritable Bowel Syndrome (IBS) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Irritable Bowel Syndrome (IBS) Key assessments Patient Segmentation in Irritable Bowel Syndrome (IBS) Irritable Bowel Syndrome (IBS) Risk & Burden Factors driving growth in a specific Irritable Bowel Syndrome (IBS) patient ...
January 2022
60 pages
Juvenile Idiopathic arthritis (JIA) - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Juvenile Idiopathic arthritis (JIA) Key assessments Patient Segmentation in Juvenile Idiopathic arthritis (JIA) Juvenile Idiopathic arthritis (JIA) Risk & Burden Factors driving growth in a specific Juvenile Idiopathic arthritis (JIA) patient population
January 2022
60 pages
Kawasaki Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Kawasaki Disease Key assessments Patient Segmentation in Kawasaki Disease Kawasaki Disease Risk & Burden Factors driving growth in a specific Kawasaki Disease patient population
January 2022
60 pages
Larynx Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Larynx Cancer Key assessments Patient Segmentation in Larynx Cancer Larynx Cancer Risk & Burden Factors driving growth in a specific Larynx Cancer patient population
January 2022
60 pages
Late-stage chronic kidney disease (CKD) - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Late-stage chronic kidney disease (CKD) Key assessments Patient Segmentation in Late-stage chronic kidney disease (CKD) Late-stage chronic kidney disease (CKD) Risk & Burden Factors driving growth in a specific Late-stage chronic kidney disease (CKD) patient population ...
January 2022
60 pages
Lennox Gastaut Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Lennox Gastaut Syndrome Key assessments Patient Segmentation in Lennox Gastaut Syndrome Lennox Gastaut Syndrome Risk & Burden Factors driving growth in a specific Lennox Gastaut Syndrome patient population
January 2022
60 pages
Lip and Oral Cavity Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Lip and Oral Cavity Cancer Key assessments Patient Segmentation in Lip and Oral Cavity Cancer Lip and Oral Cavity Cancer Risk & Burden Factors driving growth in a specific Lip and Oral Cavity Cancer patient population ...
January 2022
60 pages
Liver cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Liver cancer Key assessments Patient Segmentation in Liver cancer Liver cancer Risk & Burden Factors driving growth in a specific Liver cancer patient population
January 2022
60 pages
Liver Cirrhosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Liver Cirrhosis Key assessments Patient Segmentation in Liver Cirrhosis Liver Cirrhosis Risk & Burden Factors driving growth in a specific Liver Cirrhosis patient population
January 2022
60 pages
Major Depressive Disorder - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Major Depressive Disorder Key assessments Patient Segmentation in Major Depressive Disorder Major Depressive Disorder Risk & Burden Factors driving growth in a specific Major Depressive Disorder patient population
January 2022
60 pages
Meningitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Meningitis Key assessments Patient Segmentation in Meningitis Meningitis Risk & Burden Factors driving growth in a specific Meningitis patient population
January 2022
60 pages
Methicillin-resistant Staphylococcus aureus (MRSA) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Methicillin-resistant Staphylococcus aureus (MRSA) Key assessments Patient Segmentation in Methicillin-resistant Staphylococcus aureus (MRSA) Methicillin-resistant Staphylococcus aureus (MRSA) Risk & Burden Factors driving ...
January 2022
60 pages
Migraine - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Migraine Key assessments Patient Segmentation in Migraine Migraine Risk & Burden Factors driving growth in a specific Migraine patient population
January 2022
60 pages
Multiple Myeloma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Multiple Myeloma Key assessments Patient Segmentation in Multiple Myeloma Multiple Myeloma Risk & Burden Factors driving growth in a specific Multiple Myeloma patient population
January 2022
60 pages
Multiple Sclerosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Multiple Sclerosis Key assessments Patient Segmentation in Multiple Sclerosis Multiple Sclerosis Risk & Burden Factors driving growth in a specific Multiple Sclerosis patient population
January 2022
60 pages
Myelodysplastic Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Myelodysplastic Syndrome Key assessments Patient Segmentation in Myelodysplastic Syndrome Myelodysplastic Syndrome Risk & Burden Factors driving growth in a specific Myelodysplastic Syndrome patient population
January 2022
60 pages
Myelofibrosis (MF) - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... (MF) Pipeline Analysis Myelofibrosis (MF) Market Size and Trends Myelofibrosis (MF) Market Opportunities Impact of upcoming Therapies in Myelofibrosis (MF) Myelofibrosis (MF) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Myelofibrosis (MF) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Myelofibrosis (MF) Key assessments Patient Segmentation in Myelofibrosis (MF) Myelofibrosis (MF) Risk & Burden Factors driving growth in a specific Myelofibrosis (MF) patient population
January 2022
60 pages
Myocardial Infarction - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Myocardial Infarction Key assessments Patient Segmentation in Myocardial Infarction Myocardial Infarction Risk & Burden Factors driving growth in a specific Myocardial Infarction patient population
January 2022
60 pages
Neuroendocrine Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Neuroendocrine Carcinoma Report Assessment Current Treatment Practices in Neuroendocrine Carcinoma Unmet Needs in Neuroendocrine Carcinoma Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2022
200 pages
Neuropathic Pain - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Neuropathic Pain Key assessments Patient Segmentation in Neuropathic Pain Neuropathic Pain Risk & Burden Factors driving growth in a specific Neuropathic Pain patient population
January 2022
60 pages
Nocturnal Enuresis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Nocturnal Enuresis Key assessments Patient Segmentation in Nocturnal Enuresis Nocturnal Enuresis Risk & Burden Factors driving growth in a specific Nocturnal Enuresis patient population
January 2022
60 pages
Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Non-Hodgkin’s Lymphoma (NHL) Report Assessment Current Treatment Practices in Non-Hodgkin’s Lymphoma (NHL) Unmet Needs in Non-Hodgkin’s Lymphoma (NHL) Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
Non-Hodgkin's Lymphoma (NHL) - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Non-Hodgkin’s Lymphoma (NHL) Key assessments Patient Segmentation in Non-Hodgkin’s Lymphoma (NHL) Non-Hodgkin’s Lymphoma (NHL) Risk & Burden Factors driving growth in a specific Non-Hodgkin’s Lymphoma (NHL) patient population
January 2022
60 pages
Obsessive-Compulsive Disorder - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Obsessive-Compulsive Disorder Key assessments Patient Segmentation in Obsessive-Compulsive Disorder Obsessive-Compulsive Disorder Risk & Burden Factors driving growth in a specific Obsessive-Compulsive Disorder patient population ...
January 2022
60 pages
Oropharyngeal Cancer - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Oropharyngeal Cancer Report Assessment Current Treatment Practices in Oropharyngeal Cancer Unmet Needs in Oropharyngeal Cancer Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
Oropharyngeal Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Oropharyngeal Cancer Key assessments Patient Segmentation in Oropharyngeal Cancer Oropharyngeal Cancer Risk & Burden Factors driving growth in a specific Oropharyngeal Cancer patient population
January 2022
60 pages
Osteoarthritis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Osteoarthritis Pipeline Analysis Osteoarthritis Market Size and Trends Osteoarthritis Market Opportunities Impact of upcoming Therapies in Osteoarthritis Osteoarthritis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Osteoarthritis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Osteoarthritis Key assessments Patient Segmentation in Osteoarthritis Osteoarthritis Risk & Burden Factors driving growth in a specific Osteoarthritis patient population
January 2022
60 pages
Osteoporosis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Osteoporosis Osteoporosis Pipeline Analysis Osteoporosis Market Size and Trends Osteoporosis Market Opportunities Impact of upcoming Therapies in Osteoporosis Osteoporosis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Osteoporosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Osteoporosis Key assessments Patient Segmentation in Osteoporosis Osteoporosis Risk & Burden Factors driving growth in a specific Osteoporosis patient population
January 2022
60 pages
Paget's Disease - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Paget's Disease Pipeline Analysis Paget's Disease Market Size and Trends Paget's Disease Market Opportunities Impact of upcoming Therapies in Paget's Disease Paget's Disease Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Paget's Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Paget's Disease Key assessments Patient Segmentation in Paget's Disease Paget's Disease Risk & Burden Factors driving growth in a specific Paget's Disease patient population
January 2022
60 pages
Pancreatic Cancer - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Cancer Pipeline Analysis Pancreatic Cancer Market Size and Trends Pancreatic Cancer Market Opportunities Impact of upcoming Therapies in Pancreatic Cancer Pancreatic Cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Pancreatic Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Pancreatic Cancer Key assessments Patient Segmentation in Pancreatic Cancer Pancreatic Cancer Risk & Burden Factors driving growth in a specific Pancreatic Cancer patient population
January 2022
60 pages
Peanut Allergy - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Peanut Allergy Key assessments Patient Segmentation in Peanut Allergy Peanut Allergy Risk & Burden Factors driving growth in a specific Peanut Allergy patient population
January 2022
60 pages
Genital Warts - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Prostate cancer Pipeline Analysis Prostate cancer Market Size and Trends Prostate cancer Market Opportunities Impact of upcoming Therapies in Prostate cancer Prostate cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages